AstraZeneca"s (AZN) Lynparza Gets Another Orphan Drug Status
AstraZeneca (AZN) and partner Merck's Lynparza receive Orphan Drug designation (ODD) by the FDA for the treatment of pancreatic cancer. AstraZeneca plc AZN and .....»»
AstraZeneca announces orphan drug designation in Japan for Lynparza
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Dow Jones Newswires: AstraZeneca: FDA gives orphan drug status to two liver cancer drugs
Imfinzi and tremelimumab were given orphan drug status as treatments for hepatocellular carcinoma, or HCC......»»
AstraZeneca"s Imfinzi Gains Orphan Drug Status for SCLC
The FDA assigns an orphan drug designation to AstraZeneca's (AZN) Imfinzi for the treatment of small cell lung cancer, the mo.....»»
AstraZeneca, Merck: FDA grants LYNPARZA Orphan Drug Designation
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Astrazeneca"s Fasenra Gets Orphan Drug for Autoimmune Disease
AstraZeneca (AZN) gets Orphan Drug status for Fasenra in the United States for the treatment.....»»
AIM ImmunoTech: FDA grants Orphan Drug Designation status to Ampligen
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Intrexon will take the name of its subsidiary. That company just scored orphan status for a rare cancer drug.
Just four days after Intrexon Corp. (NASDAQ: XON) made public plans to rebrand as Precigen, its subsidiary by the same name has secured a coveted regulatory designation for its blood cancer treatment. Germantown’s Precigen Inc. has earned orpha.....»»
AstraZeneca granted FDA Orphan Drug Designation for Fasenra
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AstraZeneca granted orphan status for esophagitis treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AstraZeneca reports FDA grants saracatinib orphan drug designation
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AstraZeneca granted orphan status for pulmonary fibrosis treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Rocket Pharmaceuticals infantile malignant osteopetrosis drug gets orphan status
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AstraZeneca granted orphan status for fallopian tube, peritoneal cancers
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Immune Pharmaceuticals granted Orphan Drug status for bertilimumab
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Portola"s (PTLA) Lymphoma Candidate Gets Orphan Drug Status
Portola's (PTLA) oral Syk/JAK inhibitor, cerdulatinib, secures an orphan drug designation from the FDA for treating patients with peripheral T-ce.....»»
Corcept Therapeutics receives orphan drug status for relacorilant combination
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
The Daily Biotech Pulse: MediciNova Gets Orphan-Drug Status, KemPharm To Offer Shares, Emergent Buys Vaccine Maker
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Oct. 3) Amarin Corporation plc (NASDAQ:.....»»
AstraZeneca"s olaparib granted orphan status as pancreatic cancer treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Principia Biopharma receives FDA orphan drug status for PRN1008
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AstraZeneca's Lynparza shown to put brakes on ovarian cancer - Reuters
ReutersAstraZeneca's Lynparza shown to put brakes on ovarian cancerReutersMUNICH (Reuters) - An AstraZeneca drug that blocks a cancer cell's ability to repair its g.....»»